Two lots of diabetes drug metformin produced by Kansas City, Missouri drug maker Nostrum Laboratories are being pulled from pharmacy shelves over concerns that they might be contaminated with a cancer-causing compound. The compound, known as NDMA or nitrosamine, was detected in the company’s 750mg HCI extended-release tablets at levels that exceed federal regulations.
NDMA is a naturally occurring chemical that is found in everything from the fruits you ...
continue reading...
Diabetics who take metformin will want to contact their healthcare providers after multiple recalls of the drug have occurred due to the discovery of elevated levels of a cancer-causing compound. Multiple lots of the extended release version of the drug from multiple manufacturers tested positive for the presence of NDMA, or N-Nitrosodimethylamine, in amounts that exceed FDA regulations.
According to the FDA, humans should be able to tolerate up ...
continue reading...
2020 has not been kind to Sanofi’s flagship heartburn medication Zantac. When reports first surfaced of contamination of the medication with a known carcinogen, attention immediately turned to the labs that made ranitidine, the active ingredient in Zantac. It wasn’t until researchers discovered that Zantac could be producing the carcinogen itself that calls began for a recall of the drug. The mechanism that could lead to such an occurrence, however, has not ...
As the number of lawsuits filed over NDMA contaminated Zantac continues to grow, over 140 such suits have been sent to a federal judge to be heard as a multidistrict litigation. The MDL will be the first for U.S. District Judge Robin Rosenberg who serves as a judge for the Southern District of Florida. In selecting Judge Rosenberg, the Judicial Panel on Multidistrict Litigation called her “an able ...
New concerns are emerging over the presence of a known carcinogen in the compound used to make heartburn medication Zantac. Things have taken an interesting twist however, as researchers explore the possibility that the source of the contamination may be the Zantac itself.
The issue of NDMA contamination in Zantac and other drugs based on its main ingredient first came to light last year. That was when a ...
continue reading...
Plaintiffs in valsartan-based drug lawsuits filed over possible carcinogenic contamination may have to make room for additional consumers as lawyers push for the inclusion of two other blood pressure medications, losartan and irbesartan. Batches of the drugs, in addition to valsartan, have been found to be tainted with NDMA, or nitrosodimethylamine. NDMA is a known human carcinogen and has been linked to the development of certain types ...
